EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA ‐mediated alloimmune refractoriness

J T Blake, N Rickards, J Mack, M Seftel, A Gupta

Transfusion · 2025

DOI: 10.1111/trf.18446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von J T Blake und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dalhousie University, Halifax, Canada. Hauptthemen laut MEDLINE: Blood Donation, Blood Donors, Genetic Algorithms, Histocompatibility Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune factors underlie approximately 20% of patients exhibiting platelet transfusion refractoriness (PTR). PTR can be mitigated by supplying HLA‐A and B compatible platelets to these patients. Since 2019, Canadian Blood Services has managed a program to provide compatible platelets to alloimmunized patients. This study evaluates donor pool size and ethnic diversity options to serve Canada's population. Study Design and Methods We adapted simulation‐based stem cell matching methods by generating simulated patients and matching them to existing and simulated donors using a Python algorithm. Recruitment scenarios included census‐aligned, single‐group, and meta‐heuristic–optimized distributions to enhance match rates and equity.

Results

More typed donors increase match rates, but rates vary significantly by ethnicity. Non‐Black patients achieved 95% coverage with 13,000–18,000 new donors, whereas Black patients required ~55,000 new donors. Single‐ethnicity recruitment improved the targeted group's rate but reduced overall match rates and disadvantaged other populations. A Pareto‐optimal donor mix—augmenting Black, Hispanic, Asian Pacific Islander, and Native American/First Nations donors while modestly reducing White typing—preserved or improved rates but yielded only modest gains for Black patients. A balanced strategy further prioritizing Black and Hispanic donors with slight reductions in White, Asian, and Native American/First Nations typing achieved improvements for the Black population with minimal losses for others.

Discussion

While Pareto‐optimal allocation enhances overall efficiency, targeted trade‐offs, focusing on underrepresented groups, are essential to correct persistent disparities and achieve equitable HLA‐matched platelet availability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonationBlood DonorsGenetic AlgorithmsHistocompatibility TestingPlatelet TransfusionHumansAntigens, Human PlateletCanadaEthnicityTransfusion ReactionIndigenous Canadians

Substanzen

Antigens, Human Platelet

Autor:innen und Institutionen

  • Dalhousie University, Halifax, Canada.
  • Canadian Blood Services, Ottawa, Canada.
  • Department of Medicine, McGill University, Montreal, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Blake, J. T., Rickards, N., Mack, J., Seftel, M., & Gupta, A. (2025). Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA ‐mediated alloimmune refractoriness. Transfusion. https://doi.org/10.1111/trf.18446

Vancouver

Blake JT, Rickards N, Mack J, Seftel M, Gupta A. Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA ‐mediated alloimmune refractoriness. Transfusion. 2025. doi:10.1111/trf.18446

BibTeX
@article{Blake2025,
  author = {Blake, J T and Rickards, N and Mack, J and Seftel, M and Gupta, A},
  title = {Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA ‐mediated alloimmune refractoriness},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18446}
}
Kostenlos starten →